BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan T, Sun N, He J. Exosome-Derived LncRNAs in Lung Cancer. Front Oncol 2020;10:1728. [PMID: 33072553 DOI: 10.3389/fonc.2020.01728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 He Y, Liu Y, Cha N, Gao Y, Li F, Zhang M, Luan W. Exosomal circ_0048856 derived from non-small cell lung cancer contributes to aggressive cancer progression through downregulation of miR-1287–5p. Pathology - Research and Practice 2022;232:153659. [DOI: 10.1016/j.prp.2021.153659] [Reference Citation Analysis]
2 Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol 2022;15:18. [PMID: 35236381 DOI: 10.1186/s13045-022-01235-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
3 Shi Z, Huang K, Li Z, Niu Y, Jiang L. Evaluating the expression of tumorigenic long noncoding RNAs in circulating exosomes isolated from non-small-cell lung cancer patients. Biomark Med 2022. [PMID: 35209738 DOI: 10.2217/bmm-2021-0930] [Reference Citation Analysis]
4 Taghvimi S, Vakili O, Soltani Fard E, Khatami SH, Karami N, Taheri‐anganeh M, Salehi M, Negahdari B, Ghasemi H, Movahedpour A. Exosomal microRNAs and long noncoding RNAs: Novel mediators of drug resistance in lung cancer. Journal Cellular Physiology. [DOI: 10.1002/jcp.30697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Hsu MT, Wang YK, Tseng YJ. Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment. Cancers (Basel) 2022;14:732. [PMID: 35158999 DOI: 10.3390/cancers14030732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Wang C, Zhao D, Shu X, Wang K, Wang T, Lin X, Zhang D, Xia T, Qian S, Tang M, Yang W, Hu A, Zhao Q. Protective effects of all-trans retinoic acid against gastric premalignant lesions by repressing exosomal LncHOXA10-pyruvate carboxylase axis. J Cancer Res Clin Oncol 2021. [PMID: 34632533 DOI: 10.1007/s00432-021-03820-2] [Reference Citation Analysis]
7 Shao L, Yu Q, Lu X, Zhang X, Zhuang Z. Downregulation of LINC00115 inhibits the proliferation and invasion of lung cancer cells in vitro and in vitro. Ann Transl Med 2021;9:1256. [PMID: 34532393 DOI: 10.21037/atm-21-3724] [Reference Citation Analysis]
8 Subramaniam N, Nair R, Marsden PA. Epigenetic Regulation of the Vascular Endothelium by Angiogenic LncRNAs. Front Genet 2021;12:668313. [PMID: 34512715 DOI: 10.3389/fgene.2021.668313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jiang C, Zhang N, Hu X, Wang H. Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms. Mol Cancer 2021;20:117. [PMID: 34511114 DOI: 10.1186/s12943-021-01411-w] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
10 Chen Q, Xie X. Association of Exosomal miR-210 with Signaling Pathways Implicated in Lung Cancer. Genes (Basel) 2021;12:1248. [PMID: 34440422 DOI: 10.3390/genes12081248] [Reference Citation Analysis]
11 Yang XL, Shi Y, Zhang DD, Xin R, Deng J, Wu TM, Wang HM, Wang PY, Liu JB, Li W, Ma YS, Fu D. Quantitative proteomics characterization of cancer biomarkers and treatment. Mol Ther Oncolytics 2021;21:255-63. [PMID: 34095463 DOI: 10.1016/j.omto.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]